President Donald Trump on Sept. 23 questioned the need for tougher vaccine approval standards on the part of the Food and Drug Administration (FDA), saying the plan “sounded extremely political” and would be subject to White House approval.
According to multiple media reports, including by The New York Times and The Washington Post, unnamed sources said the FDA has been developing stricter guidelines for the emergency authorization of a COVID-19 vaccine, a plan that Trump was asked about at a White House briefing.
